Pharmiweb ChannelsAll | PharmaCo | Clinical Research | R&D/BioTech | Sales/Mktg | Healthcare | Recruitment | Pharmacy | Medical Comms RSS Feed RSS Feeds RSS Feed PharmiWeb Candidate Blog RSS Feed PharmiWeb Client Blog


Press Release

ACell®, Inc. Announces Addition of Sally Maher, JD to Board of Directors

Posted on: 31 Oct 16

COLUMBIA, Md., Oct. 31, 2016 /PRNewswire/ -- ACell, Inc. today announced that Sally Maher, JD has joined the company's Board of Directors.  Maher is currently Edwards Lifesciences' Vice President of Regulatory and Clinical Affairs, Critical Care.  Prior to Edwards, she served as Senior Vice President, Compliance and Government Affairs, for Smith & Nephew Endoscopy.

"Sally brings extensive experience in Regulatory Affairs, Clinical Research, Compliance, Business Development, Reimbursement, and Quality Control for industry-leading device and pharmaceutical companies to ACell's Board.  Her background complements ACell's current Board of Directors, and her knowledgeable oversight will surely have a positive influence on the company's strategic direction," said Kyle Kerbawy, ACell's Chairman of the Board.

Maher will replace James Osborne on the ACell Board of Directors.  Mr. Osborne will continue to advise ACell as a consultant on the current medical device reimbursement landscape.

"I am enthusiastic about the opportunity to join the Board of a dynamic company like ACell that is focused on innovative, market-changing solutions in wound care and surgical soft tissue repair.  As ACell continues to advance its product development, expand its body of clinical research, and cultivate a dynamic product portfolio, I look forward to sharing my experience and guidance to support the company's ongoing growth as it advances patient care," said Maher.

Maher has also held positions with Johnson & Johnson, Pfizer Hospital Products Groups, and the US Food and Drug Administration.  She has a BA in Bacteriology from Ohio Wesleyan University and a JD from the University of Baltimore.

About ACell, Inc.

ACell, Inc. is a leading regenerative medicine company focused on the development, manufacturing and commercialization of unique proprietary extracellular matrix (ECM) products to facilitate the repair and remodeling of damaged tissues. ACell is committed to becoming and remaining an innovative leader in regenerative medical technology, offering superior healing options for doctors and patients. ACell is a privately held company and operates manufacturing facilities in Columbia, MD and Lafayette, IN. For more information, call 800-826-2926 or visit

For more information:

Editor's Details

Mike Wood

Last updated on: 31/10/2016

Share | | |
Site Map | Privacy & Security | Cookies | Terms and Conditions is Europe's leading industry-sponsored portal for the Pharmaceutical sector, providing the latest jobs, news, features and events listings.
The information provided on is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her physician.